BRCA1 intronic Alu elements drive gene rearrangements and PARP inhibitor resistance
BRCA1 mutations located within the BRCT domain result in proteasomal degradation and sensitivity to PARP inhibitors (PARPi). Here, the authors report genetic rearrangements in the BRCA1 gene that generate a BRCT-less BRCA1 protein isoform, which avoids degradation and leads to PARPi resistance.
Guardado en:
Autores principales: | Yifan Wang, Andrea J. Bernhardy, Joseph Nacson, John J. Krais, Yin-Fei Tan, Emmanuelle Nicolas, Marc R. Radke, Elizabeth Handorf, Alba Llop-Guevara, Judith Balmaña, Elizabeth M. Swisher, Violeta Serra, Suraj Peri, Neil Johnson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/67c22e7b21e74d119a7920f907472b4a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Synergistic targeting of BRCA1 mutated breast cancers with PARP and CDK2 inhibition
por: Diar Aziz, et al.
Publicado: (2021) -
RNF168-mediated localization of BARD1 recruits the BRCA1-PALB2 complex to DNA damage
por: John J. Krais, et al.
Publicado: (2021) -
Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma
por: Olga Kondrashova, et al.
Publicado: (2018) -
Synthetic viability by BRCA2 and PARP1/ARTD1 deficiencies
por: Xia Ding, et al.
Publicado: (2016) -
The Gene Rearrangement, Loss, Transfer, and Deep Intronic Variation in Mitochondrial Genomes of Conidiobolus
por: Yong Nie, et al.
Publicado: (2021)